US Stock MarketDetailed Quotes
ABVX Abivax S.A.
- 8.780
- +0.080+0.92%
Close Nov 22 16:00 ET
- 8.780
- 0.0000.00%
Post 16:00 ET
552.45MMarket Cap-2443P/E (TTM)
9.080High8.640Low259.56KVolume8.690Open8.700Pre Close2.30MTurnover0.88%Turnover RatioLossP/E (Static)62.92MShares17.02052wk High2.69P/B260.14MFloat Cap8.50952wk Low--Dividend TTM29.63MShs Float17.020Historical High--Div YieldTTM5.06%Amplitude7.995Historical Low8.858Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Abivax S.A. Stock Forum
Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model
Abivax has announced initial preclinical combination data of obefazimod and etrasimod in an inflammatory bowel disease (IBD) mouse model. The company is conducting studies with multiple oral and injectable therapies, with additional data expected in Q4 2024. The p...
No comment yet